https://www.selleckchem.com/pr....oducts/d-lin-mc3-dma
Patients with acute myocardial infarction (AMI) are usually treated with angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) if ACEIs are not tolerated. However, there is no data regarding the impact of switching from ACEIs to ARBs on long-term clinical outcomes in AMI patients with preserved left ventricular (LV) systolic function especially beyond 1year. To investigate the effectiveness of treatment with ACEIs or ARBs on clinical outcomes over 3years in AMI patients with preserved LV systoli
Like
Comment
Share
